Odyssey Therapeutics, Inc. (ODTX)

NASDAQ: ODTX · Real-Time Price · USD

18.13

+0.33 (1.85%)

At close: Jun 26, 2026, 4:00 PM EDT

18.06

-0.07 (-0.39%)

After-hours: Jun 26, 2026, 4:10 PM EDT

Odyssey Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	35.72	41.69	59.14	52.55	241.04
Short-Term Investments	140.03	139.67	70.22	134.45	-
Cash & Short-Term Investments	175.75	181.36	129.35	187	241.04
Cash Growth	35.87%	40.20%	-30.83%	-22.42%	-
Other Current Assets	9.35	9.3	6.16	5.54	7.67
Total Current Assets	185.1	190.66	135.51	192.54	248.71
Net Property, Plant & Equipment	24.48	26.01	39.47	46.73	52.77
Other Intangible Assets	0.16	0.26	0.57	0.91	1.18
Goodwill	14.07	14.33	13.35	13.55	12.88
Long-Term Investments	-	35.2	-	29.1	-
Other Long-Term Assets	5.26	3.33	8.54	3.69	1.61
Total Assets	229.07	269.79	197.44	286.52	317.15
Accounts Payable	8.22	7.87	6.32	7.73	8.05
Accrued Expenses	8.62	13.39	17.52	10.5	11.39
Current Portion of Leases	5.37	5.21	4.58	3.86	1.72
Other Current Liabilities	-	-	-	-	1.63
Total Current Liabilities	22.21	26.48	28.42	22.09	22.8
Long-Term Debt	-	-	-	-	4.76
Long-Term Leases	20.75	21.9	26.43	30.52	34.38
Other Long-Term Liabilities	6.24	6.13	10.22	8.41	8.2
Total Long-Term Liabilities	27	28.03	36.65	38.94	47.34
Total Liabilities	49.21	54.51	65.07	61.02	70.14
Common Stock	-	-	-	0	0
Additional Paid-in Capital	82.85	79.62	38.31	27.24	15.73
Accumulated Other Comprehensive Income	-0.15	0.25	-1.34	-0.86	-2.18
Retained Earnings	-606.4	-568.14	-419.49	-289.09	-158.17
Total Common Shareholders' Equity	-523.69	-488.28	-382.53	-262.71	-144.62
Minority Interest	703.56	703.56	514.89	488.21	391.63
Shareholders' Equity	179.86	215.28	132.37	225.5	247.01
Total Liabilities & Equity	229.07	269.79	197.44	286.52	317.15

SEC Filings: 10-K · 10-Q